PR Stories
Medical Xpress: Anti-RAS antibodies show poor reliability in recognizing RAS proteins
October 5, 2017
Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio co-authored a paper published Sept. 26 in Science Signaling that looks at the reliability of a common research tool to study RAS cancer mutations. RAS mutations are implicated in several cancers, including lung, colorectal, and pancreatic ductal carcinoma. The three RAS genes are the […]
CPRIT (YouTube) Dr. Peter Houghton on Childhood Cancer Research
October 4, 2017
CPRIT TV: Dr. Peter Houghton on Childhood Cancer Research
October 4, 2017
“Dr. Peter Houghton, Director of the Greehey Children’s Cancer Research Institute at The University of Texas Health Science Center at San Antonio, discusses CPRIT and childhood cancer research.” Houghton Lab
UT Health SA Newsroom: Greehey scientists contribute to study of RAS-sensing antibodies
September 28, 2017
Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are the most frequently mutated […]
TEXAS PUBLIC RADIO: About 1,800 Children Die Of Cancer Every Year In The U.S.
September 25, 2017
More than 15,000 children and adolescents up to 19 years old will receive a cancer diagnosis this year, according to the National Cancer Institute. After accidents, cancer is the second leading cause of death in children ages 1 to 14. Conditions most commonly affecting children include leukemia, lymphoma, and tumors affecting the bones or neural systems.
SA Express-News: Childhood cancer needs more attention
September 24, 2017
September is Childhood Cancer Awareness Month. Many citizens in our community may not realize that San Antonio is home to the Greehey Children’s Cancer Research Institute — the largest freestanding pediatric cancer research facility in Texas and one of the few research institutes worldwide devoted exclusively to childhood cancer. During this important month for childhood […]
Cancer Knowledge Network: We Must Consider New Strategies to Deliver Health Care to Childhood Cancer Survivors
September 21, 2017
The Lancet: The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Researchers at St. Jude Children’s Research Hospital reported data collected retrospectively through the St. Jude Lifetime Cohort Study (SJLIFE). Patients selected for inclusion in this study had previously received their cancer treatment at St. Jude, had […]
NIH: Searching for Less Toxic Cancer Treatments for Kids (Aune Lab)
September 21, 2017
Advances in cancer treatment mean that today, more than 4 out of 5 children diagnosed with cancer will survive and remain cancer-free for at least 5 years after diagnosis. Many of these children will ultimately be considered cured of their cancer. However, the chances of either developing a life-threatening health problem or dying early as […]
Cancer Knowledge Network: The Financial Impact of Surviving Childhood Cancer
September 7, 2017
Journal of Clinical Oncology — Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Researchers evaluated self-reported household income data available through the Childhood Cancer Survivor Study (CCSS). The overall goal of this important study was to evaluate the prevalence of survivor financial burden and to identify correlations between percentage […]
Familial Cancer: Discovery of mutations in homologous recombination genes in African-American women with breast cancer
September 2, 2017
Yuan Chun Ding 1, Aaron W Adamson 1, Linda Steele 1, Adam M Bailis 2, Esther M John 3 4, Gail Tomlinson 5 6, Susan L Neuhausen 7 Abstract African-American women are more likely to develop aggressive breast cancer at younger ages and experience poorer cancer prognoses than non-Hispanic Caucasians. Deficiency in the repair of DNA by homologous recombination (HR) is associated with cancer development, suggesting that mutations in genes […]